{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:25:11Z","timestamp":1787181911091,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119835","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:23:58Z","timestamp":1786022638000},"page":"119835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real-time breath metabolomic profiling reveals a volatile signature associated with lung cancer"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5238-372X","authenticated-orcid":false,"given":"Kai","family":"Fricke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Herth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1486-3603","authenticated-orcid":false,"given":"Diego M.","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriane A.","family":"Sievi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gaisl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1561-2870","authenticated-orcid":false,"given":"Carolin","family":"Steinack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2026.119835_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119835_bib2","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170070","article-title":"Progress and prospects of early detection in lung cancer","volume":"7","author":"Blandin Knight","year":"2017","journal-title":"Open. Biol."},{"key":"10.1016\/j.biopha.2026.119835_bib3","doi-asserted-by":"crossref","unstructured":"N.L.S.T.R. Team, Reduced lung-cancer mortality with low-dose computed tomographic screening, New England Journal of Medicine 365(5) (2011) 395\u2013409.","DOI":"10.1056\/NEJMoa1102873"},{"issue":"6","key":"10.1016\/j.biopha.2026.119835_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"New. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.119835_bib5","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.cllc.2016.01.001","article-title":"Proportion of non-small-cell lung cancer patients that would have been eligible for lung cancer screening","volume":"17","author":"Wu","year":"2016","journal-title":"Clin. Lung Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2026.119835_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3190","article-title":"Prevalence of Lung Cancer Screening in the US, 2022","volume":"7","author":"Henderson","year":"2024","journal-title":"JAMA Netw. Open."},{"issue":"5","key":"10.1016\/j.biopha.2026.119835_bib7","article-title":"Implementing Lung Cancer Screening in Europe: taking a systems approach","volume":"3","author":"Wait","year":"2022","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.biopha.2026.119835_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.xjon.2022.11.021","article-title":"The majority of patients with resectable incidental lung cancers are ineligible for lung cancer screening","volume":"13","author":"Zhou","year":"2023","journal-title":"JTCVS Open."},{"key":"10.1016\/j.biopha.2026.119835_bib9","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fphar.2024.1516650","article-title":"Metabolic reprogramming in lung cancer and its clinical implication","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119835_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.lungcan.2022.12.003","article-title":"Mapping the landscape of lung cancer breath analysis: a scoping review (ELCABA)","volume":"175","author":"Schmidt","year":"2023","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2026.119835_bib11","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.21037\/jtd-24-1001","article-title":"Collection methods of exhaled volatile organic compounds for lung cancer screening and diagnosis: a systematic review","volume":"16","author":"He","year":"2024","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119835_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/thoraxjnl-2020-215667","article-title":"Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases","volume":"76","author":"Ibrahim","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.biopha.2026.119835_bib13","article-title":"Practical applications of secondary\/extractive electrospray ionization (SESI): a versatile tool for real-time chemical analysis","author":"Luo","year":"2025","journal-title":"Mass. Spectrom. Rev."},{"issue":"19","key":"10.1016\/j.biopha.2026.119835_bib14","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1007\/s00216-019-01764-8","article-title":"Standardization procedures for real-time breath analysis by secondary electrospray ionization high-resolution mass spectrometry","volume":"411","author":"Singh","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.biopha.2026.119835_bib15","series-title":"Breath and Blood Metabolomics: A Comparative Study Using SESI-HRMS\/MS and UHPLC-ESI-HRMS\/MS","author":"Tang","year":"2025"},{"issue":"1","key":"10.1016\/j.biopha.2026.119835_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12951-025-03526-4","article-title":"Advanced strategy for cancer detection based on volatile organic compounds in breath","volume":"23","author":"Jia","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119835_bib17","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/ab9f8b","article-title":"Real-time breath analysis of exhaled compounds upon peppermint oil ingestion by secondary electrospray ionization-high resolution mass spectrometry: technical aspects","volume":"14","author":"Gisler","year":"2020","journal-title":"J. Breath. Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119835_bib18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJMoa1214726","article-title":"Probability of cancer in pulmonary nodules detected on first screening CT","volume":"369","author":"McWilliams","year":"2013","journal-title":"New. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119835_bib19","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1378\/chest.128.4.2490","article-title":"Clinical prediction model to characterize pulmonary nodules: validation and added value of 18 F-fluorodeoxyglucose positron emission tomography","volume":"128","author":"Herder","year":"2005","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.biopha.2026.119835_bib20","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jama.2021.0377","article-title":"Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US preventive services task force","volume":"325","author":"Jonas","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119835_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12880-020-00469-0","article-title":"Utility of FDG PET\/CT for assessment of lung nodules identified during low dose computed tomography screening","volume":"20","author":"Hadique","year":"2020","journal-title":"BMC Med. Imaging"},{"key":"10.1016\/j.biopha.2026.119835_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.lungcan.2021.02.006","article-title":"Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection","volume":"154","author":"Chen","year":"2021","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2026.119835_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/metabo13020203","article-title":"Non-invasive lung cancer diagnostics through metabolites in exhaled breath: influence of the disease variability and comorbidities","volume":"13","author":"Temerdashev","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.biopha.2026.119835_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339230","article-title":"Secondary electrospray ionization-high resolution mass spectrometry (SESI-HRMS) fingerprinting enabled treatment monitoring of pulmonary carcinoma cells in real time","volume":"1189","author":"Choueiry","year":"2022","journal-title":"Anal. Chim. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2026.119835_bib25","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/ad48a9","article-title":"Exhaled breath analysis in patients with potentially curative lung cancer undergoing surgery: a longitudinal study","volume":"18","author":"Herth","year":"2024","journal-title":"J. Breath. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119835_bib26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1186\/s12885-024-12537-7","article-title":"Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis","volume":"24","author":"Fan","year":"2024","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2026.119835_bib27","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/2\/4\/046001","article-title":"On the use of Tedlar\u00ae bags for breath-gas sampling and analysis","volume":"2","author":"Beauchamp","year":"2008","journal-title":"J. Breath. Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119835_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11306-017-1241-8","article-title":"Exhaled breath analysis: a review of 'breath-taking' methods for off-line analysis","volume":"13","author":"Lawal","year":"2017","journal-title":"Metabolomics"},{"issue":"12","key":"10.1016\/j.biopha.2026.119835_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114555","article-title":"Exhaled breath analysis for lung cancer detection using ion mobility spectrometry","volume":"9","author":"Handa","year":"2014","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.biopha.2026.119835_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12127-011-0078-5","article-title":"Significant different volatile biomarker during bronchoscopic ion mobility spectrometry investigation of patients suffering lung carcinoma","volume":"14","author":"Baumbach","year":"2011","journal-title":"Int. J. Ion. Mobil. Spectrom."},{"issue":"4","key":"10.1016\/j.biopha.2026.119835_bib31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/10408347.2021.1981226","article-title":"Breath analysis by secondary electro-spray ionization-mass spectrometry to interrogate biologically significant metabolites non-invasively","volume":"53","author":"Blanco","year":"2023","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2026.119835_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.132","article-title":"Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer","volume":"7","author":"Qu","year":"2016","journal-title":"Cell. Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119835_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","article-title":"Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer","volume":"9","author":"Ma","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119835_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820976664","article-title":"The tumorigenic effect of sphingosine kinase 1 and its potential therapeutic target","volume":"27","author":"Wang","year":"2020","journal-title":"Cancer Control."},{"key":"10.1016\/j.biopha.2026.119835_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102318","article-title":"Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer","volume":"53","author":"Furqan","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119835_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2466-13-43","article-title":"Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry","volume":"13","author":"Bikov","year":"2013","journal-title":"BMC Pulm. Med."},{"issue":"17","key":"10.1016\/j.biopha.2026.119835_bib37","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1039\/D3AN00786C","article-title":"Influence of ventilatory parameters on the concentration of exhaled volatile organic compounds in mechanically ventilated patients","volume":"148","author":"Romano","year":"2023","journal-title":"Analyst"},{"issue":"6","key":"10.1016\/j.biopha.2026.119835_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00408-011-9324-1","article-title":"Bronchoscopically obtained volatile biomarkers in lung cancer","volume":"189","author":"Darwiche","year":"2011","journal-title":"Lung"},{"issue":"3","key":"10.1016\/j.biopha.2026.119835_bib39","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1183\/09031936.00125411","article-title":"Breath analysis during one-lung ventilation in cancer patients","volume":"40","author":"Kischkel","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119835_bib40","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1038\/srep07312","article-title":"Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation","volume":"4","author":"Wang","year":"2014","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119835_bib41","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/abb478","article-title":"Spatial mapping of VOC exhalation by means of bronchoscopic sampling","volume":"14","author":"Fuchs","year":"2020","journal-title":"J. Breath. Res."},{"issue":"16","key":"10.1016\/j.biopha.2026.119835_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27165258","article-title":"Exhaled aldehydes as biomarkers for lung diseases: a narrative review","volume":"27","author":"Floss","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119835_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101384","article-title":"Identification of lung cancer breath biomarkers based on perioperative breathomics testing: a prospective observational study","volume":"47","author":"Wang","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.biopha.2026.119835_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/biomethods\/bpz014","article-title":"Digging deeper into volatile organic compounds associated with cancer","volume":"4","author":"Janfaza","year":"2019","journal-title":"Biol. Methods Protoc."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:54:01Z","timestamp":1787180041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"alternative-id":["S0753332226008711"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119835","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-time breath metabolomic profiling reveals a volatile signature associated with lung cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119835"}}